N-substituted derivatives of 3R,4R-ethyl-[(1-methyl-1H-imidazol-

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

548110, 5483147, A61K 31415, C07D40300

Patent

active

052644499

ABSTRACT:
The present invention relates to new carbonyl 3R, 4R-ethyl-[(1-methyl-1H-imidazol-5-yl)methyl] -2-pyrrolidinone derivatives carrying a carboxyester-type lipophilic moiety on the pyrrolidinone nitrogen. More particularly, the present invention concerns new N-substituted carbonyl-3R,4R-ethyl-[(1-methyl-1H-imidazol-5-yl) methyl]-2-pyrrolidinone derivatives of the formula (I): ##STR1## wherein R is an optionally substituted hydrocarbon group, and pharmaceutically acceptable acid addition salts thereof.
The new compounds of the formula (I) are potent ocular hypotensives that are valuable antiglaucoma agents. They are also targeted for use in the treatment of so-called dry eye.

REFERENCES:
patent: 3470197 (1969-09-01), Van Dyke
J. Pharm. Sci., 62, 2021 (1973).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

N-substituted derivatives of 3R,4R-ethyl-[(1-methyl-1H-imidazol- does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with N-substituted derivatives of 3R,4R-ethyl-[(1-methyl-1H-imidazol-, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-substituted derivatives of 3R,4R-ethyl-[(1-methyl-1H-imidazol- will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1849147

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.